Hemic and Lymphatic Diseases: News and Research on Hematologic Diseases

MeSH tree: C15.378

New therapeutic target expands options for multiple myeloma

In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...

page 1 from 40